Broadband UVB revisited: Is the narrowband UVB fad limiting our therapeutic options?

Journal of Dermatological Treatment

Volumn 21, Issue 6, 2010, Pages 326-330

  Pugashetti, Rupa ^a   Lim, Henry W ^b   Koo, John ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Broadband UVB; Narrowband UVB; Phototherapy; Pruritus; Psoriasis

Indexed keywords

CALCIPOTRIOL; CLOBETASOL; FEXOFENADINE; HYDROXYZINE; PIMECROLIMUS; TACROLIMUS; TAZAROTENE; TRIAMCINOLONE; ULOBETASOL PROPIONATE;

ADULT; AGED; ARTICLE; ASCARIASIS; ATOPIC DERMATITIS; BROADBAND ULTRAVIOLET B; CLINICAL ARTICLE; EOSINOPHILIA; FEMALE; HUMAN; NARROWBAND ULTRAVIOLET B; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS VULGARIS; PUVA; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; SKIN ALLERGY; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION;

ADULT; AGED; DERMATITIS, ATOPIC; FEMALE; HUMANS; MIDDLE AGED; PRURITUS; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 77957954887     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546630903341986     Document Type: Article

References (39)

1. Caricchio R, Reap EA, Cohen PL. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis. J Immunol. 1998;161:241-251.
2. Duthie MS, Kimber I, Norval M. The effects of ultraviolet radiation on the human immune system. Br J Dermatol. 1999;140:995-1009.
3. Lebwohl M, Ting PT, Koo JY. Psoriasis treatment: Traditional therapy. Ann Rheum Dis. 2005;64(suppl II): 83-86.
4. Coven TR, Burack LH, Gilleaudeau R, Keogh M, Ozawa M, Krueger JG. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psori-asis in patients compared with broadband UV-B. Arch Dermatol. 1997;133:1514-1522.
5. Gupta G, Long J, Tillman DM. The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures. Br J Dermatol. 1999;140: 887-890.
6. British Photodermatology Group. An appraisal ofnarrowband (TL-01) UVB phototherapy: British photodermatology group workshop report (April 1996). Br J Dermatol. 1997;137:327-330.
7. Barbagallo J, Spann CT, Tutrone WD, Weinberg JM. Narrowband UVB phototherapy for the treatment of psoriasis: A review and update. Cutis. 2001;68:345-347.
8. Dawe RS. A quantitative review of studies comparing the efficacy of narrow-band and broad-band ultraviolet B for psoriasis. BrJDermatol. 2003;149:669-672.
9. Gambichler T, Breuckmann F, Boms S, Altmeyer P, Kreuter A. Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol. 2005;52:660-70.
10. Goeckerman W. Treatment of psoriasis. Northwest Med. 1925;24:229-231.
11. Larko O, Swanbeck G. Home solarium treatment ofpsoriasis. BrJDermatol. 1979;101:13-16.
12. Adrian RM, Parrish JA, Momtaz TK, Karlin MJ. Outpatient phototherapy for psoriasis. Arch Dermatol. 1981;117:623-6.
13. BoerJ, Schothorst AA, Suurmond D. UV-B phototherapy of psoriasis. Dermatologica. 1980;161:250-258.
14. Walters IB, Burack LH, Coven TR, Gilleaudeau P, KruegerJG. Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris. J Am Acad Dermatol. 1999;40:893-900.
15. Storbeck K, Holzle E, Schurer N, Lehmann P, Plewig G. Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy forpsoriasis. J Am Acad Dermatol. 1993;28:227-231.
16. Picot E, Meunier L, Picot-Debeze MC, Peyron JL, Meynadier J. Treatment of psoriasis with a 311-nm UVB lamp. BrJDermatol. 1992;127:509-512.
17. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311-nm UVB phototherapy? An effective treatment for psoriasis. Br J Dermatol. 1988;119:691-696.
18. Karvonen J, Kokkonen EL, Ruotsalainen E. 311-nm UVB lamps in the treatment of psoriasis with the Ingram regimen. Acta Derm Venereol. 1989;69:82-85.
19. Gilchrest BA, Rowe JW, Brown RS, Steinman TI, Arndt KA. Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. Ann Intern Med. 1979;91:17-21.
20. Szepietowski J. Selected elements of the pathogenesis of pruritus in haemodialysis patients. Med Sci Monit. 1996; 2:342-347.
21. Cohen EP, Russell TJ, Garancis JC. Mast cells and calcium in severe uremic itching. Am J Med Sci. 1992;306:360-5.
22. Gilchrest BA. Ultraviolet phototherapy of uremic pruritus. IntJDermatol. 1979;18:741-748.
23. Hsu MM, Yang CC. Uraemic pruritus responsive to broad-band ultraviolet (UV) B therapy does not readily respond to narrowband UVB therapy. BrJDermatol. 2003;149:888-889.
24. Blachley JD, Blankenship DM, Menter A, Parker TF 3rd, Knochel JP. Uremic pruritus: Skin divalent ion content and response to ultraviolet phototherapy. Am J Kidney Dis. 1985;5:237-241.
25. Baldo A, Sammarco E, Monfrecola M. UVB phototherapy for pruritus in polycythaemia vera. Dermatol Treat. 1996;7:245-246.
26. Buchness MR, Lim HW, Hatcher VA, Sanchez M, Soter NA. Eosinophilic pustular folliculitis in the acquired immuno-deficiency syndrome: Treatment with ultraviolet B photo-therapy. N Engl J Med. 1988;318:1183-1186.
27. Pardo RJ, Bogaert MA, Penneys NS, Byrne GE Jr, Ruiz P. UVB phototherapy of the pruritic papular eruption of the acquired immunodeficiency syndrome. J Am Acad Dermatol. 1992;26:423-428.
28. Krutmann J. Phototherapy for atopic dermatitis. Clin Exp Dermatol. 2000;25:552-558.
29. JeklerJ, Larko O. UVB phototherapy ofatopic dermatitis. Br J Dermatol. 1988;119:697-705.
30. Van Weelden H, Baart de la Faille H, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. BrJDermatol. 1988;119:11-19.
31. Larko O. Treatment of psoriasis with a new UVB-lamp. Acta Derm Venereol. 1989;69:357-359.
32. Tuchinda C, Lim HW, Strickland FM, Guzmán EA, Wong HK. Comparison of broadband UVB, narrowband UVB, broadband UVA and UVA1 on activation of apop-totic pathways in human peripheral blood mononuclear cells. Photodermatol Photoimmunol Photomed. 2007;23: 2-9.
33. Lee E, Koo JY, Berger T. UVB phototherapy and skin cancer risk: A review of the literature. Int J Dermatol. 2005;44: 355-360.
34. Lebwohl M. Should we switch from combination UVA/UVB phototherapy units to narrowband UVB? Photodermatol Photoimmunol Photomed. 2002;18:44-46.
35. Pittelkow MR, Perry HO, Müller SA, Maughan WZ, O'Brien PC Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study. Arch Dermatol. 1981;117:465-468.
36. Weischer M, Blum A, Eberhard F, Röcken M, Berneburg M. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: A first retrospective study. Acta Derm Venereol. 2004;84: 370-374.
37. Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol. 2008;159:931-935.
38. Berneburg M, Röcken M, Benedix F. Phototherapy with narrowband vs. broadband UVB. Acta Derm Venereol. 2005;85:98-108.
39. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PM. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol. 1998;134: 1532-1540.